Found: 105
Select item for more details and to access through your institution.
Post hoc analyses of SHIFT and PARADIGM‐HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: "Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial" by Bocchi et al
- Published in:
- ESC Heart Failure, 2018, v. 5, n. 6, p. 1069, doi. 10.1002/ehf2.12355
- By:
- Publication type:
- Article
Age and SPARC Change the Extracellular Matrix Composition of the Left Ventricle.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Age and SPARC Change the Extracellular Matrix Composition of the Left Ventricle.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/810562
- By:
- Publication type:
- Article
Suppressing angiotensinogen synthesis attenuates kidney cyst formation in a Pkd1 mouse model.
- Published in:
- FASEB Journal, 2016, v. 30, n. 1, p. 370, doi. 10.1096/fj.15-279299
- By:
- Publication type:
- Article
β<sub>3</sub> Integrin-mediated ubiquitination activates survival signaling during myocardial hypertrophy.
- Published in:
- FASEB Journal, 2009, v. 23, n. 8, p. 2759, doi. 10.1096/fj.08-127480
- By:
- Publication type:
- Article
426 A Beat Away from Precision Medicine: Characterizing Human Cardiac Fibroblast Responsiveness to Hemodynamic Unloading in Heart Failure with Reduced Ejection Fraction.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Phenotypic characterization of primary cardiac fibroblasts from patients with HFpEF.
- Published in:
- PLoS ONE, 2022, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0262479
- By:
- Publication type:
- Article
Palliative Care for Advanced Heart Failure in a Department of Veterans Affairs Regional Hospice Program: Patient Selection, a Treatment Protocol, and Clinical Course.
- Published in:
- Journal of Palliative Medicine, 2017, v. 20, n. 10, p. 1068, doi. 10.1089/jpm.2017.0035
- By:
- Publication type:
- Article
Regional contributions to impaired myocardial mechanical function in heart failure with preserved ejection fraction.
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2023, v. 24, n. 8, p. 1110, doi. 10.1093/ehjci/jead062
- By:
- Publication type:
- Article
Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: The CAPACITY HFpEF Randomized Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Left ventricle function and post-transcriptional events with exercise training in pigs.
- Published in:
- PLoS ONE, 2024, v. 18, n. 2, p. 1, doi. 10.1371/journal.pone.0292243
- By:
- Publication type:
- Article
Correction: Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Correction: Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prognostic value of brain natriuretic peptide vs history of heart failure hospitalization in a large real‐world population.
- Published in:
- Clinical Cardiology, 2020, v. 43, n. 12, p. 1501, doi. 10.1002/clc.23468
- By:
- Publication type:
- Article
Peter C. Gazes: Physician, teacher, scholar.
- Published in:
- Clinical Cardiology, 2003, v. 26, n. 3, p. 158, doi. 10.1002/clc.4960260313
- By:
- Publication type:
- Article
Stroke in patients with heart failure and reduced or preserved ejection fraction.
- Published in:
- European Heart Journal, 2023, v. 44, n. 31, p. 2998, doi. 10.1093/eurheartj/ehad338
- By:
- Publication type:
- Article
Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 24, p. 2202, doi. 10.1093/eurheartj/ehad210
- By:
- Publication type:
- Article
Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox.
- Published in:
- European Heart Journal, 2023, v. 44, n. 13, p. 1136, doi. 10.1093/eurheartj/ehad083
- By:
- Publication type:
- Article
Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction.
- Published in:
- European Heart Journal, 2023, v. 44, n. 8, p. 668, doi. 10.1093/eurheartj/ehac801
- By:
- Publication type:
- Article
Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation.
- Published in:
- European Heart Journal, 2022, v. 43, n. 42, p. 4469, doi. 10.1093/eurheartj/ehac487
- By:
- Publication type:
- Article
GUIDE-HF trial of pulmonary artery pressure monitoring in heart failure: impact of the COVID-19 pandemic.
- Published in:
- European Heart Journal, 2022, v. 43, n. 27, p. 2603, doi. 10.1093/eurheartj/ehac114
- By:
- Publication type:
- Article
Effects of sacubitril/valsartan according to polypharmacy status in PARAGON‐HF.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 5, p. 1125, doi. 10.1002/ejhf.3223
- By:
- Publication type:
- Article
Baroreflex activation therapy in patients with heart failure and a reduced ejection fraction: Long‐term outcomes.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 1051, doi. 10.1002/ejhf.3232
- By:
- Publication type:
- Article
Interatrial shunt therapy in advanced heart failure: Outcomes from the open‐label cohort of the RELIEVE‐HF trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 1078, doi. 10.1002/ejhf.3215
- By:
- Publication type:
- Article
Clinical implications of subclinical left ventricular dysfunction in heart failure with preserved ejection fraction: The PARAGON‐HF study.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 871, doi. 10.1002/ejhf.3167
- By:
- Publication type:
- Article
Independent prognostic importance of blood urea nitrogen to creatinine ratio in heart failure.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 2, p. 245, doi. 10.1002/ejhf.3114
- By:
- Publication type:
- Article
Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 12, p. 2202, doi. 10.1002/ejhf.3044
- By:
- Publication type:
- Article
Knowledge about self‐efficacy and outcomes in patients with heart failure and reduced ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 10, p. 1831, doi. 10.1002/ejhf.2944
- By:
- Publication type:
- Article
Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with reduced and preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 9, p. 1606, doi. 10.1002/ejhf.2962
- By:
- Publication type:
- Article
Changes in mid‐regional pro‐adrenomedullin during treatment with sacubitril/valsartan.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1396, doi. 10.1002/ejhf.2957
- By:
- Publication type:
- Article
Incremental prognostic value of biomarkers in PARADIGM‐HF.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1406, doi. 10.1002/ejhf.2887
- By:
- Publication type:
- Article
Clinical characteristics of heart failure with reduced ejection fraction patients with rare pathogenic variants in dilated cardiomyopathy‐associated genes: A subgroup analysis of the PARADIGM‐HF trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1256, doi. 10.1002/ejhf.2886
- By:
- Publication type:
- Article
Impact of multimorbidity on mortality in heart failure with reduced ejection fraction: which comorbidities matter most? An analysis of PARADIGM‐HF and ATMOSPHERE.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 5, p. 687, doi. 10.1002/ejhf.2856
- By:
- Publication type:
- Article
Health‐related quality of life outcomes in PARAGON‐HF.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2264, doi. 10.1002/ejhf.2738
- By:
- Publication type:
- Article
Baroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta‐analysis of randomized controlled trials.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 9, p. 1665, doi. 10.1002/ejhf.2573
- By:
- Publication type:
- Article
Effect of sacubitril/valsartan on investigator‐reported ventricular arrhythmias in PARADIGM‐HF.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 551, doi. 10.1002/ejhf.2419
- By:
- Publication type:
- Article
Influence of study discontinuation during the run‐in period on the estimated efficacy of sacubitril/valsartan in the PARAGON‐HF trial.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 12, p. 2085, doi. 10.1002/ejhf.2262
- By:
- Publication type:
- Article
Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM‐HF trial.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 9, p. 1518, doi. 10.1002/ejhf.2259
- By:
- Publication type:
- Article
Serum potassium and outcomes in heart failure with preserved ejection fraction: a post‐hoc analysis of the PARAGON‐HF trial.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 5, p. 776, doi. 10.1002/ejhf.2134
- By:
- Publication type:
- Article
Prevalence and incidence of intra‐ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM‐HF and ATMOSPHERE.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 12, p. 2370, doi. 10.1002/ejhf.1972
- By:
- Publication type:
- Article
Serum uric acid, influence of sacubitril–valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON‐HF.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2093, doi. 10.1002/ejhf.1984
- By:
- Publication type:
- Article
Serum potassium in the PARADIGM‐HF trial.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2056, doi. 10.1002/ejhf.1987
- By:
- Publication type:
- Article
The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Liver function and prognosis, and influence of sacubitril/valsartan in patients with heart failure with reduced ejection fraction.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Heart failure with preserved ejection fraction in Asia.
- Published in:
- 2019
- By:
- Publication type:
- journal article